miRagen and Archemix to Collaborate on Conjugated Aptamer-microRNA Therapeutics

News   Jul 27, 2009

 
miRagen and Archemix to Collaborate on Conjugated Aptamer-microRNA Therapeutics
 
 
 

RELATED ARTICLES

Giant Viruses Invent Their Own Genes

News

Three new members have been isolated and added to the Pandoravirus family. This strange family of viruses, with their giant genomes and many genes with no known equivalents, surprised scientists when they were discovered a few years ago. This new study notes that pandoraviruses appear to be factories for new genes – and therefore new functions.

READ MORE

Therapeutic CRISPR Could Be Cancer Risk

News

Therapeutic use of gene editing with the so-called CRISPR-Cas9 technique may inadvertently increase the risk of cancer, according to a new study. Researchers say that more studies are required in order to guarantee the safety of these ‘molecular scissors’ for gene-editing therapies.

READ MORE

Who Owns the Ocean? One Company Has Registered Half of All Marine Gene Patents

News

A single corporation has registered nearly half of all existing patents associated with genes from marine organisms, according to a new study. Researchers from the University of British Columbia and the Stockholm Resilience Centre examined the patents associated with marine species and found that BASF, the world’s largest chemical manufacturer, has registered 47 per cent of the 12,998 genetic sequences from 862 marine species.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy